Arbutus Biopharma (ABUS) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.13
0.2
0.54
0.87

Details

Expected EPS
-0.03
Actual EPS
0.87
Surprise EPS
0.9
Surprise Percent
+3,000%

Description

Arbutus Biopharma (ABUS) has reported earnings of 0.87 per share for Q2 2026.

0 Comments

Share your thoughts